Skip to Main Content

Author Details

Kathleen M MacQueen
and Clinical Sciences Division
1984
62
19
PMIDPaper TitleJournal TitlePublished Year
36146913Exploring intersectional stigma and COVID-19 impact on human immunodeficiency virus service provision for African Americans in a Southern city.J Clin Nurs2023
37347876Ethical research when abortion access is legally restricted.Science2023
29649249Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.PLoS One2018
30123100Rapid organizational network analysis to assess coordination of services for HIV testing clients: an exploratory study.J HIV AIDS Soc Serv2018
30334608It is not just about "the trial": the critical role of effective engagement and participatory practices for moving the HIV research field forward.J Int AIDS Soc2018
30334601Using theory of change frameworks to develop evaluation strategies for research engagement: results of a pre-pilot study.J Int AIDS Soc2018
28702454Corrigendum: Relationship between Human Immunodeficiency Virus (HIV) Knowledge, HIV-Related Stigma, and HIV Testing among Young Black Adults in a Southeastern City.Front Public Health2017
28423992Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa.Cult Health Sex2017
28349049Relationship between Human Immunodeficiency Virus (HIV) Knowledge, HIV-Related Stigma, and HIV Testing among Young Black Adults in a Southeastern City.Front Public Health2017
28708847Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey.PLoS One2017
28812339Young people, HIV, and life goals.J Int AIDS Soc2017
26945585Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa.AIDS Behav2016
27197795HIV Vaccine Awareness Day: sustaining the momentum.J Int AIDS Soc2016
27142091Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings.J Int AIDS Soc2016
27368311Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials.J Empir Res Hum Res Ethics2016
26829257Concurrency and Other Sexual Risk Behaviors Among Black Young Adults in a Southeastern City.AIDS Educ Prev2016
25893817HIV Testing Experience and Risk Behavior Among Sexually Active Black Young Adults: A CBPR-Based Study Using Respondent-Driven Sampling in Durham, North Carolina.Am J Community Psychol2015
26126899Evaluating community engagement in global health research: the need for metrics.BMC Med Ethics2015
24647763Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study.AIDS Behav2014
25727984Curriculum development to increase minority research literacy for HIV prevention research: a CBPR approach.Prog Community Health Partnersh2014
25285564Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.AIDS Care2014
25229403The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa.PLoS One2014
25224617An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings.J Int AIDS Soc2014
25157899Comparison of closed-ended, open-ended, and perceived informed consent comprehension measures for a mock HIV prevention trial among women in Tanzania.PLoS One2014
24643315Adherence in the CAPRISA 004 tenofovir gel microbicide trial.AIDS Behav2014
24633717Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial.AIDS Behav2014
23561044Microbicide clinical trial adherence: insights for introduction.J Int AIDS Soc2013
21968079Framing the social in biomedical HIV prevention trials: a 20-year retrospective.J Int AIDS Soc2011
20210540Acceptability of PrEP for HIV prevention among women at high risk for HIV.J Womens Health (Larchmt)2010
20569146The exploitation of "Exploitation" in the tenofovir prep trial in Cameroon: Lessons learned from media coverage of an HIV prevention trial.J Empir Res Hum Res Ethics2010
19051397Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.Sex Transm Dis2008
19385753Partnering for Care in HIV Prevention Trials.J Empir Res Hum Res Ethics2008
18816162Ethical and practical issues associated with aggregating databases.PLoS Med2008
18767319International perspectives on the collection, storage, and testing of human biospecimens in HIV research.IRB2008
17453597Community perspectives on care options for HIV prevention trial participants.AIDS Care2007
17667340Pregnancy prevention practices among women with multiple partners in an HIV prevention trial.J Acquir Immune Defic Syndr2007
17403499Practice brief: adolescents and HIV clinical trials: ethics, culture, and context.J Assoc Nurses AIDS Care2007
17166081How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak out.AIDS Educ Prev2006
19385819Women's Autonomy and Informed Consent in Microbicides Clinical Trials.J Empir Res Hum Res Ethics2006
15894154The multiple layers of prevention science research.Am J Prev Med2005
16195446AIDS. Promote HIV chemoprophylaxis research, don't prevent it.Science2005
15367072Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type.Health Psychol2004
15249291Ethics, practice, and research in public health.Am J Public Health2004
15341046Ethical challenges in international HIV prevention research.Account Res2004
12833902Back to the rough ground: working in international HIV prevention as ethical debates continue.IRB2003
12907494Ethics guidance for HIV prevention trials.BMJ2003
11176270Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.J Acquir Immune Defic Syndr2001
11726368What is community? An evidence-based definition for participatory public health.Am J Public Health2001
10048905Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials.J Acquir Immune Defic Syndr Hum Retrovirol1999
10430236Per-contact risk of human immunodeficiency virus transmission between male sexual partners.Am J Epidemiol1999
  • 1 - 50 of 62

Recommended Authors

Rhode Island Hospital
Career Start Year 2016
Number of shared co-authors 0
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 2016
Number of shared co-authors 0
College of Nursing, Florida State University
Career Start Year 2015
Number of shared co-authors 0
Johns Hopkins School of Medicine
Career Start Year 2012
Number of shared co-authors 0
University of Washington
Career Start Year 2012
Number of shared co-authors 0
College of Medicine, Drexel University
Career Start Year 2011
Number of shared co-authors 0
Wake Forest School of Medicine, University of North Carolina
Career Start Year 2010
Number of shared co-authors 0
The Hospital of the University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
Rollins School of Public Health, Emory University
Career Start Year 2010
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
Vanderbilt University Medical Center (VUMC), Institute for Global Health
Career Start Year 2010
Number of shared co-authors 0
University of Washington
Career Start Year 2009
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2007
Number of shared co-authors 0
Tufts University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Brown University
Career Start Year 2003
Number of shared co-authors 0
University of Mississippi Medical Center
Career Start Year 2002
Number of shared co-authors 0
City University of New York Institute of Implementation Science and Population Health
Career Start Year 1999
Number of shared co-authors 0
Morehouse School of Medicine
Career Start Year 1998
Number of shared co-authors 0
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1995
Number of shared co-authors 0
School of Public Health, University of Alabama at Birmingham
Career Start Year 1995
Number of shared co-authors 0
university of california los angeles Center for Clinical AIDS Research & Education
Career Start Year 1992
Number of shared co-authors 1
The University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 0
Rollins School of Public Health, Emory University
Career Start Year 1990
Number of shared co-authors 0
Dell Medical School, University of Texas
Career Start Year 1989
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 1989
Number of shared co-authors 1
Yale University
Career Start Year 1989
Number of shared co-authors 0
University of Pennsylvania.
Career Start Year 1980
Number of shared co-authors 0
Centers for Disease Control and Prevention.
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 6
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 1
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Arizona State University.
Co-authored papers 1
Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation
Co-authored papers 1
Center for Law and the Biosciences, Stanford University
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Vanderbilt University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1